Within your health trust how many patients are currently [within the past 3 months] being treated with the following agent and indication;
MabThera IV (rituximab)
MabThera SC (rituximab)
Truxima (rituximab)
Rixathon (rituximab)
Gazyvaro (obinutuzumab)
Imbruvica (ibrutinib)
Zydelig (idelalisib)
Arzerra (ofatumumab)
Please can you state the number of patients for the above drugs for the following indications;
Follicular lymphoma [C82.0 to C82.9]
Diffuse Large B-cell Lymphoma [C83.3]
Chronic Lymphocytic Leukaemia [C91.1]
All other B-cell, haematological malignancies (all C82, C83, C85, C88.0, C88.4 codes not listed above]
Rheumatoid Arthritis [M5, M6]

How many Truxima patients were naive or new to biologic therapy?

Download response Treatments with specific products. 071217